WealthShield Partners LLC Has $3.12 Million Stake in UnitedHealth Group Incorporated $UNH

WealthShield Partners LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.0% during the 2nd quarter, HoldingsChannel reports. The fund owned 10,003 shares of the healthcare conglomerate’s stock after purchasing an additional 1,071 shares during the period. WealthShield Partners LLC’s holdings in UnitedHealth Group were worth $3,120,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its position in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Markel Group Inc. raised its position in shares of UnitedHealth Group by 4.9% during the first quarter. Markel Group Inc. now owns 28,014 shares of the healthcare conglomerate’s stock worth $14,672,000 after acquiring an additional 1,300 shares during the last quarter. Independent Wealth Network Inc. increased its position in UnitedHealth Group by 8.4% during the 1st quarter. Independent Wealth Network Inc. now owns 503 shares of the healthcare conglomerate’s stock valued at $263,000 after purchasing an additional 39 shares during the period. Finally, Jennison Associates LLC boosted its stake in shares of UnitedHealth Group by 105.4% in the 1st quarter. Jennison Associates LLC now owns 502,076 shares of the healthcare conglomerate’s stock valued at $262,962,000 after purchasing an additional 257,599 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $321.44 on Friday. The stock’s fifty day moving average price is $347.65 and its two-hundred day moving average price is $320.06. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $622.83. The firm has a market cap of $291.17 billion, a PE ratio of 16.78, a PEG ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the company earned $7.15 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s payout ratio is presently 46.14%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on UNH shares. Mizuho boosted their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. JPMorgan Chase & Co. increased their target price on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. The Goldman Sachs Group began coverage on UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target for the company. TD Cowen upped their price target on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a report on Thursday, October 30th. Finally, Leerink Partners set a $410.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.